A detailed history of Dkrt Investments Corp. transactions in Biogen Inc. stock. As of the latest transaction made, Dkrt Investments Corp. holds 2,500 shares of BIIB stock, worth $418,875. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$418,875
Previous $314 Million 11.54%
% of portfolio
0.08%
Previous 0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$113.38 - $135.49 $283,450 - $338,725
2,500 New
2,500 $314 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dkrt Investments Corp. Portfolio

Follow Dkrt Investments Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dkrt Investments Corp., based on Form 13F filings with the SEC.

News

Stay updated on Dkrt Investments Corp. with notifications on news.